The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Human Papilloma Virus Testing Market Research Report 2025

Global Human Papilloma Virus Testing Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1713701

No of Pages : 106

Ask Your Query

Synopsis

Human Papilloma Virus Testing is the procedure to test if the patient have the Human Papilloma Virus

The global Human Papilloma Virus Testing market was valued at US$ 757 million in 2023 and is anticipated to reach US$ 1103.2 million by 2030, witnessing a CAGR of 5.4% during the forecast period 2024-2030.

North American market for Human Papilloma Virus Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Human Papilloma Virus Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Human Papilloma Virus Testing in Diagnostic Centers is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Human Papilloma Virus Testing include Roche, AgilentTechnologies, Inc., Becton, DickinsonandCompany, QiagenN.V., ThermoFisherScientificInc., AbbottLaboratories, HologicInc., CepheidInc. and SeegenEInc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Human Papilloma Virus Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Papilloma Virus Testing.

Report Scope

The Human Papilloma Virus Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Papilloma Virus Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Human Papilloma Virus Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Roche
  • AgilentTechnologies, Inc.
  • Becton, DickinsonandCompany
  • QiagenN.V.
  • ThermoFisherScientificInc.
  • AbbottLaboratories
  • HologicInc.
  • CepheidInc.
  • SeegenEInc.
  • TakarABioInc.
  • DaAnGenECo., Ltd.of SunYat-SenUniversity
  • PromegACorporation
  • GreinerBio-OnEInternationalGmbH(GreinerHoldingAG)
  • EnzoBiochemInc.
  • NorgenBiotek Corp.
  • DiagCorBiosciencEIncLtd
  • HybribioLimited
  • ZytovisionGmbH
  • ArborVitACorporation
  • Medical& BiologicalLaboratoriesCo., Ltd
  • Fujirebio Diagnostics, Inc.

Segment by Type

  • Pap Smear Test
  • HPV DNA Test

Segment by Application

  • Diagnostic Centers
  • Hospitals
  • Clinic

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Papilloma Virus Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Papilloma Virus Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Pap Smear Test
1.2.3 HPV DNA Test
1.3 Market by Application
1.3.1 Global Human Papilloma Virus Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Diagnostic Centers
1.3.3 Hospitals
1.3.4 Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Papilloma Virus Testing Market Perspective (2019-2030)
2.2 Human Papilloma Virus Testing Growth Trends by Region
2.2.1 Global Human Papilloma Virus Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Human Papilloma Virus Testing Historic Market Size by Region (2019-2024)
2.2.3 Human Papilloma Virus Testing Forecasted Market Size by Region (2025-2030)
2.3 Human Papilloma Virus Testing Market Dynamics
2.3.1 Human Papilloma Virus Testing Industry Trends
2.3.2 Human Papilloma Virus Testing Market Drivers
2.3.3 Human Papilloma Virus Testing Market Challenges
2.3.4 Human Papilloma Virus Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Papilloma Virus Testing Players by Revenue
3.1.1 Global Top Human Papilloma Virus Testing Players by Revenue (2019-2024)
3.1.2 Global Human Papilloma Virus Testing Revenue Market Share by Players (2019-2024)
3.2 Global Human Papilloma Virus Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Human Papilloma Virus Testing Revenue
3.4 Global Human Papilloma Virus Testing Market Concentration Ratio
3.4.1 Global Human Papilloma Virus Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Papilloma Virus Testing Revenue in 2023
3.5 Human Papilloma Virus Testing Key Players Head office and Area Served
3.6 Key Players Human Papilloma Virus Testing Product Solution and Service
3.7 Date of Enter into Human Papilloma Virus Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Papilloma Virus Testing Breakdown Data by Type
4.1 Global Human Papilloma Virus Testing Historic Market Size by Type (2019-2024)
4.2 Global Human Papilloma Virus Testing Forecasted Market Size by Type (2025-2030)
5 Human Papilloma Virus Testing Breakdown Data by Application
5.1 Global Human Papilloma Virus Testing Historic Market Size by Application (2019-2024)
5.2 Global Human Papilloma Virus Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Human Papilloma Virus Testing Market Size (2019-2030)
6.2 North America Human Papilloma Virus Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Human Papilloma Virus Testing Market Size by Country (2019-2024)
6.4 North America Human Papilloma Virus Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human Papilloma Virus Testing Market Size (2019-2030)
7.2 Europe Human Papilloma Virus Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Human Papilloma Virus Testing Market Size by Country (2019-2024)
7.4 Europe Human Papilloma Virus Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Papilloma Virus Testing Market Size (2019-2030)
8.2 Asia-Pacific Human Papilloma Virus Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Human Papilloma Virus Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Human Papilloma Virus Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Human Papilloma Virus Testing Market Size (2019-2030)
9.2 Latin America Human Papilloma Virus Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Human Papilloma Virus Testing Market Size by Country (2019-2024)
9.4 Latin America Human Papilloma Virus Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Papilloma Virus Testing Market Size (2019-2030)
10.2 Middle East & Africa Human Papilloma Virus Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Human Papilloma Virus Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Human Papilloma Virus Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Human Papilloma Virus Testing Introduction
11.1.4 Roche Revenue in Human Papilloma Virus Testing Business (2019-2024)
11.1.5 Roche Recent Development
11.2 AgilentTechnologies, Inc.
11.2.1 AgilentTechnologies, Inc. Company Detail
11.2.2 AgilentTechnologies, Inc. Business Overview
11.2.3 AgilentTechnologies, Inc. Human Papilloma Virus Testing Introduction
11.2.4 AgilentTechnologies, Inc. Revenue in Human Papilloma Virus Testing Business (2019-2024)
11.2.5 AgilentTechnologies, Inc. Recent Development
11.3 Becton, DickinsonandCompany
11.3.1 Becton, DickinsonandCompany Company Detail
11.3.2 Becton, DickinsonandCompany Business Overview
11.3.3 Becton, DickinsonandCompany Human Papilloma Virus Testing Introduction
11.3.4 Becton, DickinsonandCompany Revenue in Human Papilloma Virus Testing Business (2019-2024)
11.3.5 Becton, DickinsonandCompany Recent Development
11.4 QiagenN.V.
11.4.1 QiagenN.V. Company Detail
11.4.2 QiagenN.V. Business Overview
11.4.3 QiagenN.V. Human Papilloma Virus Testing Introduction
11.4.4 QiagenN.V. Revenue in Human Papilloma Virus Testing Business (2019-2024)
11.4.5 QiagenN.V. Recent Development
11.5 ThermoFisherScientificInc.
11.5.1 ThermoFisherScientificInc. Company Detail
11.5.2 ThermoFisherScientificInc. Business Overview
11.5.3 ThermoFisherScientificInc. Human Papilloma Virus Testing Introduction
11.5.4 ThermoFisherScientificInc. Revenue in Human Papilloma Virus Testing Business (2019-2024)
11.5.5 ThermoFisherScientificInc. Recent Development
11.6 AbbottLaboratories
11.6.1 AbbottLaboratories Company Detail
11.6.2 AbbottLaboratories Business Overview
11.6.3 AbbottLaboratories Human Papilloma Virus Testing Introduction
11.6.4 AbbottLaboratories Revenue in Human Papilloma Virus Testing Business (2019-2024)
11.6.5 AbbottLaboratories Recent Development
11.7 HologicInc.
11.7.1 HologicInc. Company Detail
11.7.2 HologicInc. Business Overview
11.7.3 HologicInc. Human Papilloma Virus Testing Introduction
11.7.4 HologicInc. Revenue in Human Papilloma Virus Testing Business (2019-2024)
11.7.5 HologicInc. Recent Development
11.8 CepheidInc.
11.8.1 CepheidInc. Company Detail
11.8.2 CepheidInc. Business Overview
11.8.3 CepheidInc. Human Papilloma Virus Testing Introduction
11.8.4 CepheidInc. Revenue in Human Papilloma Virus Testing Business (2019-2024)
11.8.5 CepheidInc. Recent Development
11.9 SeegenEInc.
11.9.1 SeegenEInc. Company Detail
11.9.2 SeegenEInc. Business Overview
11.9.3 SeegenEInc. Human Papilloma Virus Testing Introduction
11.9.4 SeegenEInc. Revenue in Human Papilloma Virus Testing Business (2019-2024)
11.9.5 SeegenEInc. Recent Development
11.10 TakarABioInc.
11.10.1 TakarABioInc. Company Detail
11.10.2 TakarABioInc. Business Overview
11.10.3 TakarABioInc. Human Papilloma Virus Testing Introduction
11.10.4 TakarABioInc. Revenue in Human Papilloma Virus Testing Business (2019-2024)
11.10.5 TakarABioInc. Recent Development
11.11 DaAnGenECo., Ltd.of SunYat-SenUniversity
11.11.1 DaAnGenECo., Ltd.of SunYat-SenUniversity Company Detail
11.11.2 DaAnGenECo., Ltd.of SunYat-SenUniversity Business Overview
11.11.3 DaAnGenECo., Ltd.of SunYat-SenUniversity Human Papilloma Virus Testing Introduction
11.11.4 DaAnGenECo., Ltd.of SunYat-SenUniversity Revenue in Human Papilloma Virus Testing Business (2019-2024)
11.11.5 DaAnGenECo., Ltd.of SunYat-SenUniversity Recent Development
11.12 PromegACorporation
11.12.1 PromegACorporation Company Detail
11.12.2 PromegACorporation Business Overview
11.12.3 PromegACorporation Human Papilloma Virus Testing Introduction
11.12.4 PromegACorporation Revenue in Human Papilloma Virus Testing Business (2019-2024)
11.12.5 PromegACorporation Recent Development
11.13 GreinerBio-OnEInternationalGmbH(GreinerHoldingAG)
11.13.1 GreinerBio-OnEInternationalGmbH(GreinerHoldingAG) Company Detail
11.13.2 GreinerBio-OnEInternationalGmbH(GreinerHoldingAG) Business Overview
11.13.3 GreinerBio-OnEInternationalGmbH(GreinerHoldingAG) Human Papilloma Virus Testing Introduction
11.13.4 GreinerBio-OnEInternationalGmbH(GreinerHoldingAG) Revenue in Human Papilloma Virus Testing Business (2019-2024)
11.13.5 GreinerBio-OnEInternationalGmbH(GreinerHoldingAG) Recent Development
11.14 EnzoBiochemInc.
11.14.1 EnzoBiochemInc. Company Detail
11.14.2 EnzoBiochemInc. Business Overview
11.14.3 EnzoBiochemInc. Human Papilloma Virus Testing Introduction
11.14.4 EnzoBiochemInc. Revenue in Human Papilloma Virus Testing Business (2019-2024)
11.14.5 EnzoBiochemInc. Recent Development
11.15 NorgenBiotek Corp.
11.15.1 NorgenBiotek Corp. Company Detail
11.15.2 NorgenBiotek Corp. Business Overview
11.15.3 NorgenBiotek Corp. Human Papilloma Virus Testing Introduction
11.15.4 NorgenBiotek Corp. Revenue in Human Papilloma Virus Testing Business (2019-2024)
11.15.5 NorgenBiotek Corp. Recent Development
11.16 DiagCorBiosciencEIncLtd
11.16.1 DiagCorBiosciencEIncLtd Company Detail
11.16.2 DiagCorBiosciencEIncLtd Business Overview
11.16.3 DiagCorBiosciencEIncLtd Human Papilloma Virus Testing Introduction
11.16.4 DiagCorBiosciencEIncLtd Revenue in Human Papilloma Virus Testing Business (2019-2024)
11.16.5 DiagCorBiosciencEIncLtd Recent Development
11.17 HybribioLimited
11.17.1 HybribioLimited Company Detail
11.17.2 HybribioLimited Business Overview
11.17.3 HybribioLimited Human Papilloma Virus Testing Introduction
11.17.4 HybribioLimited Revenue in Human Papilloma Virus Testing Business (2019-2024)
11.17.5 HybribioLimited Recent Development
11.18 ZytovisionGmbH
11.18.1 ZytovisionGmbH Company Detail
11.18.2 ZytovisionGmbH Business Overview
11.18.3 ZytovisionGmbH Human Papilloma Virus Testing Introduction
11.18.4 ZytovisionGmbH Revenue in Human Papilloma Virus Testing Business (2019-2024)
11.18.5 ZytovisionGmbH Recent Development
11.19 ArborVitACorporation
11.19.1 ArborVitACorporation Company Detail
11.19.2 ArborVitACorporation Business Overview
11.19.3 ArborVitACorporation Human Papilloma Virus Testing Introduction
11.19.4 ArborVitACorporation Revenue in Human Papilloma Virus Testing Business (2019-2024)
11.19.5 ArborVitACorporation Recent Development
11.20 Medical& BiologicalLaboratoriesCo., Ltd
11.20.1 Medical& BiologicalLaboratoriesCo., Ltd Company Detail
11.20.2 Medical& BiologicalLaboratoriesCo., Ltd Business Overview
11.20.3 Medical& BiologicalLaboratoriesCo., Ltd Human Papilloma Virus Testing Introduction
11.20.4 Medical& BiologicalLaboratoriesCo., Ltd Revenue in Human Papilloma Virus Testing Business (2019-2024)
11.20.5 Medical& BiologicalLaboratoriesCo., Ltd Recent Development
11.21 Fujirebio Diagnostics, Inc.
11.21.1 Fujirebio Diagnostics, Inc. Company Detail
11.21.2 Fujirebio Diagnostics, Inc. Business Overview
11.21.3 Fujirebio Diagnostics, Inc. Human Papilloma Virus Testing Introduction
11.21.4 Fujirebio Diagnostics, Inc. Revenue in Human Papilloma Virus Testing Business (2019-2024)
11.21.5 Fujirebio Diagnostics, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Human Papilloma Virus Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Pap Smear Test
Table 3. Key Players of HPV DNA Test
Table 4. Global Human Papilloma Virus Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Human Papilloma Virus Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Human Papilloma Virus Testing Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Human Papilloma Virus Testing Market Share by Region (2019-2024)
Table 8. Global Human Papilloma Virus Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Human Papilloma Virus Testing Market Share by Region (2025-2030)
Table 10. Human Papilloma Virus Testing Market Trends
Table 11. Human Papilloma Virus Testing Market Drivers
Table 12. Human Papilloma Virus Testing Market Challenges
Table 13. Human Papilloma Virus Testing Market Restraints
Table 14. Global Human Papilloma Virus Testing Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Human Papilloma Virus Testing Market Share by Players (2019-2024)
Table 16. Global Top Human Papilloma Virus Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Papilloma Virus Testing as of 2023)
Table 17. Ranking of Global Top Human Papilloma Virus Testing Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Human Papilloma Virus Testing Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Human Papilloma Virus Testing Product Solution and Service
Table 21. Date of Enter into Human Papilloma Virus Testing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Human Papilloma Virus Testing Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Human Papilloma Virus Testing Revenue Market Share by Type (2019-2024)
Table 25. Global Human Papilloma Virus Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Human Papilloma Virus Testing Revenue Market Share by Type (2025-2030)
Table 27. Global Human Papilloma Virus Testing Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Human Papilloma Virus Testing Revenue Market Share by Application (2019-2024)
Table 29. Global Human Papilloma Virus Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Human Papilloma Virus Testing Revenue Market Share by Application (2025-2030)
Table 31. North America Human Papilloma Virus Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Human Papilloma Virus Testing Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Human Papilloma Virus Testing Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Human Papilloma Virus Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Human Papilloma Virus Testing Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Human Papilloma Virus Testing Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Human Papilloma Virus Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Human Papilloma Virus Testing Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Human Papilloma Virus Testing Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Human Papilloma Virus Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Human Papilloma Virus Testing Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Human Papilloma Virus Testing Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Human Papilloma Virus Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Human Papilloma Virus Testing Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Human Papilloma Virus Testing Market Size by Country (2025-2030) & (US$ Million)
Table 46. Roche Company Detail
Table 47. Roche Business Overview
Table 48. Roche Human Papilloma Virus Testing Product
Table 49. Roche Revenue in Human Papilloma Virus Testing Business (2019-2024) & (US$ Million)
Table 50. Roche Recent Development
Table 51. AgilentTechnologies, Inc. Company Detail
Table 52. AgilentTechnologies, Inc. Business Overview
Table 53. AgilentTechnologies, Inc. Human Papilloma Virus Testing Product
Table 54. AgilentTechnologies, Inc. Revenue in Human Papilloma Virus Testing Business (2019-2024) & (US$ Million)
Table 55. AgilentTechnologies, Inc. Recent Development
Table 56. Becton, DickinsonandCompany Company Detail
Table 57. Becton, DickinsonandCompany Business Overview
Table 58. Becton, DickinsonandCompany Human Papilloma Virus Testing Product
Table 59. Becton, DickinsonandCompany Revenue in Human Papilloma Virus Testing Business (2019-2024) & (US$ Million)
Table 60. Becton, DickinsonandCompany Recent Development
Table 61. QiagenN.V. Company Detail
Table 62. QiagenN.V. Business Overview
Table 63. QiagenN.V. Human Papilloma Virus Testing Product
Table 64. QiagenN.V. Revenue in Human Papilloma Virus Testing Business (2019-2024) & (US$ Million)
Table 65. QiagenN.V. Recent Development
Table 66. ThermoFisherScientificInc. Company Detail
Table 67. ThermoFisherScientificInc. Business Overview
Table 68. ThermoFisherScientificInc. Human Papilloma Virus Testing Product
Table 69. ThermoFisherScientificInc. Revenue in Human Papilloma Virus Testing Business (2019-2024) & (US$ Million)
Table 70. ThermoFisherScientificInc. Recent Development
Table 71. AbbottLaboratories Company Detail
Table 72. AbbottLaboratories Business Overview
Table 73. AbbottLaboratories Human Papilloma Virus Testing Product
Table 74. AbbottLaboratories Revenue in Human Papilloma Virus Testing Business (2019-2024) & (US$ Million)
Table 75. AbbottLaboratories Recent Development
Table 76. HologicInc. Company Detail
Table 77. HologicInc. Business Overview
Table 78. HologicInc. Human Papilloma Virus Testing Product
Table 79. HologicInc. Revenue in Human Papilloma Virus Testing Business (2019-2024) & (US$ Million)
Table 80. HologicInc. Recent Development
Table 81. CepheidInc. Company Detail
Table 82. CepheidInc. Business Overview
Table 83. CepheidInc. Human Papilloma Virus Testing Product
Table 84. CepheidInc. Revenue in Human Papilloma Virus Testing Business (2019-2024) & (US$ Million)
Table 85. CepheidInc. Recent Development
Table 86. SeegenEInc. Company Detail
Table 87. SeegenEInc. Business Overview
Table 88. SeegenEInc. Human Papilloma Virus Testing Product
Table 89. SeegenEInc. Revenue in Human Papilloma Virus Testing Business (2019-2024) & (US$ Million)
Table 90. SeegenEInc. Recent Development
Table 91. TakarABioInc. Company Detail
Table 92. TakarABioInc. Business Overview
Table 93. TakarABioInc. Human Papilloma Virus Testing Product
Table 94. TakarABioInc. Revenue in Human Papilloma Virus Testing Business (2019-2024) & (US$ Million)
Table 95. TakarABioInc. Recent Development
Table 96. DaAnGenECo., Ltd.of SunYat-SenUniversity Company Detail
Table 97. DaAnGenECo., Ltd.of SunYat-SenUniversity Business Overview
Table 98. DaAnGenECo., Ltd.of SunYat-SenUniversity Human Papilloma Virus Testing Product
Table 99. DaAnGenECo., Ltd.of SunYat-SenUniversity Revenue in Human Papilloma Virus Testing Business (2019-2024) & (US$ Million)
Table 100. DaAnGenECo., Ltd.of SunYat-SenUniversity Recent Development
Table 101. PromegACorporation Company Detail
Table 102. PromegACorporation Business Overview
Table 103. PromegACorporation Human Papilloma Virus Testing Product
Table 104. PromegACorporation Revenue in Human Papilloma Virus Testing Business (2019-2024) & (US$ Million)
Table 105. PromegACorporation Recent Development
Table 106. GreinerBio-OnEInternationalGmbH(GreinerHoldingAG) Company Detail
Table 107. GreinerBio-OnEInternationalGmbH(GreinerHoldingAG) Business Overview
Table 108. GreinerBio-OnEInternationalGmbH(GreinerHoldingAG) Human Papilloma Virus Testing Product
Table 109. GreinerBio-OnEInternationalGmbH(GreinerHoldingAG) Revenue in Human Papilloma Virus Testing Business (2019-2024) & (US$ Million)
Table 110. GreinerBio-OnEInternationalGmbH(GreinerHoldingAG) Recent Development
Table 111. EnzoBiochemInc. Company Detail
Table 112. EnzoBiochemInc. Business Overview
Table 113. EnzoBiochemInc. Human Papilloma Virus Testing Product
Table 114. EnzoBiochemInc. Revenue in Human Papilloma Virus Testing Business (2019-2024) & (US$ Million)
Table 115. EnzoBiochemInc. Recent Development
Table 116. NorgenBiotek Corp. Company Detail
Table 117. NorgenBiotek Corp. Business Overview
Table 118. NorgenBiotek Corp. Human Papilloma Virus Testing Product
Table 119. NorgenBiotek Corp. Revenue in Human Papilloma Virus Testing Business (2019-2024) & (US$ Million)
Table 120. NorgenBiotek Corp. Recent Development
Table 121. DiagCorBiosciencEIncLtd Company Detail
Table 122. DiagCorBiosciencEIncLtd Business Overview
Table 123. DiagCorBiosciencEIncLtd Human Papilloma Virus Testing Product
Table 124. DiagCorBiosciencEIncLtd Revenue in Human Papilloma Virus Testing Business (2019-2024) & (US$ Million)
Table 125. DiagCorBiosciencEIncLtd Recent Development
Table 126. HybribioLimited Company Detail
Table 127. HybribioLimited Business Overview
Table 128. HybribioLimited Human Papilloma Virus Testing Product
Table 129. HybribioLimited Revenue in Human Papilloma Virus Testing Business (2019-2024) & (US$ Million)
Table 130. HybribioLimited Recent Development
Table 131. ZytovisionGmbH Company Detail
Table 132. ZytovisionGmbH Business Overview
Table 133. ZytovisionGmbH Human Papilloma Virus Testing Product
Table 134. ZytovisionGmbH Revenue in Human Papilloma Virus Testing Business (2019-2024) & (US$ Million)
Table 135. ZytovisionGmbH Recent Development
Table 136. ArborVitACorporation Company Detail
Table 137. ArborVitACorporation Business Overview
Table 138. ArborVitACorporation Human Papilloma Virus Testing Product
Table 139. ArborVitACorporation Revenue in Human Papilloma Virus Testing Business (2019-2024) & (US$ Million)
Table 140. ArborVitACorporation Recent Development
Table 141. Medical& BiologicalLaboratoriesCo., Ltd Company Detail
Table 142. Medical& BiologicalLaboratoriesCo., Ltd Business Overview
Table 143. Medical& BiologicalLaboratoriesCo., Ltd Human Papilloma Virus Testing Product
Table 144. Medical& BiologicalLaboratoriesCo., Ltd Revenue in Human Papilloma Virus Testing Business (2019-2024) & (US$ Million)
Table 145. Medical& BiologicalLaboratoriesCo., Ltd Recent Development
Table 146. Fujirebio Diagnostics, Inc. Company Detail
Table 147. Fujirebio Diagnostics, Inc. Business Overview
Table 148. Fujirebio Diagnostics, Inc. Human Papilloma Virus Testing Product
Table 149. Fujirebio Diagnostics, Inc. Revenue in Human Papilloma Virus Testing Business (2019-2024) & (US$ Million)
Table 150. Fujirebio Diagnostics, Inc. Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human Papilloma Virus Testing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Human Papilloma Virus Testing Market Share by Type: 2023 VS 2030
Figure 3. Pap Smear Test Features
Figure 4. HPV DNA Test Features
Figure 5. Global Human Papilloma Virus Testing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Human Papilloma Virus Testing Market Share by Application: 2023 VS 2030
Figure 7. Diagnostic Centers Case Studies
Figure 8. Hospitals Case Studies
Figure 9. Clinic Case Studies
Figure 10. Human Papilloma Virus Testing Report Years Considered
Figure 11. Global Human Papilloma Virus Testing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Human Papilloma Virus Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Human Papilloma Virus Testing Market Share by Region: 2023 VS 2030
Figure 14. Global Human Papilloma Virus Testing Market Share by Players in 2023
Figure 15. Global Top Human Papilloma Virus Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Papilloma Virus Testing as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Human Papilloma Virus Testing Revenue in 2023
Figure 17. North America Human Papilloma Virus Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Human Papilloma Virus Testing Market Share by Country (2019-2030)
Figure 19. United States Human Papilloma Virus Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Human Papilloma Virus Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Human Papilloma Virus Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Human Papilloma Virus Testing Market Share by Country (2019-2030)
Figure 23. Germany Human Papilloma Virus Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Human Papilloma Virus Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Human Papilloma Virus Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Human Papilloma Virus Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Human Papilloma Virus Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Human Papilloma Virus Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Human Papilloma Virus Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Human Papilloma Virus Testing Market Share by Region (2019-2030)
Figure 31. China Human Papilloma Virus Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Human Papilloma Virus Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Human Papilloma Virus Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Human Papilloma Virus Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Human Papilloma Virus Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Human Papilloma Virus Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Human Papilloma Virus Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Human Papilloma Virus Testing Market Share by Country (2019-2030)
Figure 39. Mexico Human Papilloma Virus Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Human Papilloma Virus Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Human Papilloma Virus Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Human Papilloma Virus Testing Market Share by Country (2019-2030)
Figure 43. Turkey Human Papilloma Virus Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Human Papilloma Virus Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Roche Revenue Growth Rate in Human Papilloma Virus Testing Business (2019-2024)
Figure 46. AgilentTechnologies, Inc. Revenue Growth Rate in Human Papilloma Virus Testing Business (2019-2024)
Figure 47. Becton, DickinsonandCompany Revenue Growth Rate in Human Papilloma Virus Testing Business (2019-2024)
Figure 48. QiagenN.V. Revenue Growth Rate in Human Papilloma Virus Testing Business (2019-2024)
Figure 49. ThermoFisherScientificInc. Revenue Growth Rate in Human Papilloma Virus Testing Business (2019-2024)
Figure 50. AbbottLaboratories Revenue Growth Rate in Human Papilloma Virus Testing Business (2019-2024)
Figure 51. HologicInc. Revenue Growth Rate in Human Papilloma Virus Testing Business (2019-2024)
Figure 52. CepheidInc. Revenue Growth Rate in Human Papilloma Virus Testing Business (2019-2024)
Figure 53. SeegenEInc. Revenue Growth Rate in Human Papilloma Virus Testing Business (2019-2024)
Figure 54. TakarABioInc. Revenue Growth Rate in Human Papilloma Virus Testing Business (2019-2024)
Figure 55. DaAnGenECo., Ltd.of SunYat-SenUniversity Revenue Growth Rate in Human Papilloma Virus Testing Business (2019-2024)
Figure 56. PromegACorporation Revenue Growth Rate in Human Papilloma Virus Testing Business (2019-2024)
Figure 57. GreinerBio-OnEInternationalGmbH(GreinerHoldingAG) Revenue Growth Rate in Human Papilloma Virus Testing Business (2019-2024)
Figure 58. EnzoBiochemInc. Revenue Growth Rate in Human Papilloma Virus Testing Business (2019-2024)
Figure 59. NorgenBiotek Corp. Revenue Growth Rate in Human Papilloma Virus Testing Business (2019-2024)
Figure 60. DiagCorBiosciencEIncLtd Revenue Growth Rate in Human Papilloma Virus Testing Business (2019-2024)
Figure 61. HybribioLimited Revenue Growth Rate in Human Papilloma Virus Testing Business (2019-2024)
Figure 62. ZytovisionGmbH Revenue Growth Rate in Human Papilloma Virus Testing Business (2019-2024)
Figure 63. ArborVitACorporation Revenue Growth Rate in Human Papilloma Virus Testing Business (2019-2024)
Figure 64. Medical& BiologicalLaboratoriesCo., Ltd Revenue Growth Rate in Human Papilloma Virus Testing Business (2019-2024)
Figure 65. Fujirebio Diagnostics, Inc. Revenue Growth Rate in Human Papilloma Virus Testing Business (2019-2024)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock